Smart multifunctional GLA-nanoformulation for Fabry disease

Project Information

Smart-4-Fabry

Grant agreement ID: 720942

DOI

10.3030/720942

Project closed

EC signature date 22 November 2016

Start date 1 January 2017

End date 31 December 2020

Funded under

• INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies

Total cost

€ 5 844 508,63

EU contribution

€ 5 844 508,63

Coordinated by

CONSORCIO CENTRO DE INVESTIGACION BIOMEDICA EN RED M.P.
Spain

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Deliverables

Documents, reports (4)

Linkedin, Youtube, Twitter

Feeding and reporting activities of the social communities

Press and social media repercussion

Report on press appearances and social media repercussion

Use and dissemination Plan

Report defining the activities related to the use and dissemination of the project's results

Compilation of scientific papers published

Report with a Compilation of the scientific papers published during the project

Other (2)

Smart-4-Fabry Final Expo
Project/group presentations

Group presentation/special seminar at appropriate pharmaceutical conference

Websites, patent fillings, videos etc. (1)

Smart-4-Fabry public website

Development and follow-up of a website with the information/activities of the project

Publications

Peer reviewed articles (2)

Synthesis of Stable Cholesteryl–Polyethylene Glycol–Peptide Conjugates with Non-Disperse Polyethylene Glycol Lengths

Author(s): Edgar Cristóbal-Lecina, Daniel Pulido, Pau Martin-Malpartida, Maria J. Macias, Fernando Albericio, Miriam Royo
Published in: ACS Omega, Issue 5/10, 2020, Page(s) 5508-5519, ISSN 2470-1343
Publisher: ACS Publications
DOI: 10.1021/acsomega.0c00130

Impact of Chemical Composition on the Nanostructure and Biological Activity of α-Galactosidase-Loaded Nanovesicles for Fabry Disease Treatment

Author(s): Judit Tomsen-Melero, Solène Passemard, Natalia García-Aranda, Zamira Vanessa Díaz-Riascos, Ramon González-Rioja, Jannik Nedergaard Pedersen, Jeppe Lyngsø, Josep Merlo-Mas, Edgar Cristóbal-Lecina, José Luis Corchero, Daniel Pulido, Patricia Cámara-Sánchez, Irina Portnaya, Inbal Ionita, Simó Schwartz, Jaume Veciana, Santi Sala, Miriam Royo, Alba Córdoba, Dganit Danino, Jan Skov Pedersen,
Published in: ACS Applied Materials & Interfaces, 2021, ISSN 1944-8244
Publisher: American Chemical Society
DOI: 10.1021/acsami.0c16871

Intellectual Property Rights

Patent (3)

ES: “LIPOSOMAS FUNCIONALIZADOS ÚTILES PARA LA LIBERACIÓN DE COMPUESTOS BIOACTIVOS”.INT: “FUNCTIONALIZED LIPOSOMES USEFUL FOR THE DELIVERY OF BIOACTIVE COMPOUNDS”

Application/Publication number: ES P201231020
Date: 2012-06-29
Applicant(s): FUNDACIO PARC CIENTIFIC DE BARCELONA

ES: “LIPOSOMAS FUNCIONALIZADOS ÚTILES PARA LA LIBERACIÓN DE COMPUESTOS BIOACTIVOS”.INT: “FUNCTIONALIZED LIPOSOMES USEFUL FOR THE DELIVERY OF BIOACTIVE COMPOUNDS”

Application/Publication number: ES P201231020
Date: 2012-06-29
Applicant(s): AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS

ES: “LIPOSOMAS FUNCIONALIZADOS ÚTILES PARA LA LIBERACIÓN DE COMPUESTOS BIOACTIVOS”.INT: “FUNCTIONALIZED LIPOSOMES USEFUL FOR THE DELIVERY OF BIOACTIVE COMPOUNDS”

Application/Publication number: ES P201231020
Date: 2012-06-29
Applicant(s): CONSORCIO CENTRO DE INVESTIGACION BIOMEDICA EN RED M.P.